Evidence map›Paper›PMID 24586504›Full record

ArticlePloS one2014

Selective activation of hTRPV1 by N-geranyl cyclopropylcarboxamide, an amiloride-insensitive salt taste enhancer.

Min Jung Kim, Hee Jin Son, Yiseul Kim, Hae-Jin Kweon, Byung-Chang Suh, Vijay Lyall, Mee-Ra Rhyu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Stimulus temperature modulates the psychophysical dimensions of salt taste.American journal of physiology. Regulatory, integrative and comparative physiology · 2026
    Article
  2. Review
  3. Interactions between Chemesthesis and Taste: Role of TRPA1 and TRPV1.International journal of molecular sciences · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Min Jung KimDivision of Metabolism and Functionality Research, Korea Food Research Institute, Bundang-gu, Sungnam-si, Gyeonggi-do, Republic of Korea.
Hee Jin SonDivision of Metabolism and Functionality Research, Korea Food Research Institute, Bundang-gu, Sungnam-si, Gyeonggi-do, Republic of Korea.
Yiseul KimDivision of Metabolism and Functionality Research, Korea Food Research Institute, Bundang-gu, Sungnam-si, Gyeonggi-do, Republic of Korea.
Hae-Jin KweonDepartment of Brain Science, DaeguGyeongbuk Institute of Science and Technology (DGIST), Daegu, Republic of Korea.
Byung-Chang SuhDepartment of Brain Science, DaeguGyeongbuk Institute of Science and Technology (DGIST), Daegu, Republic of Korea.
Vijay LyallDepartment of Physiology and Biophysics, Virginia Commonwealth University, Richmond, Virginia, United States of America.
Mee-Ra RhyuDivision of Metabolism and Functionality Research, Korea Food Research Institute, Bundang-gu, Sungnam-si, Gyeonggi-do, Republic of Korea.
Korea Food Research Institute · KRDaegu Gyeongbuk Institute of Science and Technology · KRVirginia Commonwealth University · US

Funding

Nicotinic Acetylcholine Receptor Mediated Bitter Taste TransductionR01DC011569 · NIDCD · VIRGINIA COMMONWEALTH UNIVERSITY · PI LYALL, VIJAY · 2012 to 2016
$1.5M
NIDCD NIH HHS DC011569NIDCD NIH HHS R01 DC011569
6 · The paper itself

Abstract

TRPV1t, a variant of the transient receptor potential vanilloid-1 (TRPV1) has been proposed as a constitutively active, non-selective cation channel as a putative amiloride-insensitive salt taste receptor and shares many properties with TRPV1. Based on our previous chorda tympani taste nerve recordings in rodents and human sensory evaluations, we proposed that N-geranylcyclopropylcarboxamide (NGCC), a novel synthetic compound, acts as a salt taste enhancer by modulating the amiloride/benzamil-insensitive Na(+) entry pathways. As an extension of this work, we investigated NGCC-induced human TRPV1 (hTRPV1) activation using a Ca(2+)-flux signaling assay in cultured cells. NGCC enhanced Ca(2+) influx in hTRPV1-expressing cells in a dose-dependent manner (EC50 = 115 µM). NGCC-induced Ca(2+) influx was significantly attenuated by ruthenium red (RR; 30 µM), a non-specific blocker of TRP channels and capsazepine (CZP; 5 µM), a specific antagonist of TRPV1, implying that NGCC directly activates hTRPV1. TRPA1 is often co-expressed with TRPV1 in sensory neurons. Therefore, we also investigated the effects of NGCC on hTRPA1-expressing cells. Similar to hTRPV1, NGCC enhanced Ca(2+) influx in hTRPA1-expressing cells (EC50 = 83.65 µM). The NGCC-induced Ca(2+) influx in hTRPA1-expressing cells was blocked by RR (30 µM) and HC-030031 (100 µM), a specific antagonist of TRPA1. These results suggested that NGCC selectively activates TRPV1 and TRPA1 in cultured cells. These data may provide additional support for our previous hypothesis that NGCC interacts with TRPV1 variant cation channel, a putative amiloride/benzamil-insensitive salt taste pathway in the anterior taste receptive field.

Indexed as

Acid Sensing Ion ChannelsAmidesAmilorideCalcium ChannelsEpithelial Sodium ChannelsHEK293 CellsHumansMembrane PotentialsMonoterpenesNerve Tissue ProteinsSodium Chloride, DietaryTaste BudsTaste PerceptionTransfectionTransient Receptor Potential ChannelsTRPA1 Cation ChannelAcid Sensing Ion ChannelsAmidesAmilorideASIC1 protein, humanCalcium ChannelsEpithelial Sodium ChannelsMonoterpenesNerve Tissue ProteinsN-geranyl cyclopropylcarboxamideSodium Chloride, DietaryTransient Receptor Potential ChannelsTRPA1 Cation ChannelTRPA1 protein, humanTRPV1 protein, humanTRPV Cation Channels

Identifiers

PMID24586504
PMCPMC3930709
OpenAlexW1971284395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.